• 2001

Company Description

CEVEC Pharmaceuticals develops therapeutic proteins and monoclonal antibodies with human glycosylation patterns.

CEVEC Pharmaceuticals GmbH, a biopharmaceutical company, engages in developing and producing therapeutic proteins and monoclonal antibodies with human glycosylation patterns. The company was founded in 2001 and is based in Cologne, Germany.